3,822 Shares in CVS Health Corporation (NYSE:CVS) Purchased by Mission Wealth Management LP

Mission Wealth Management LP acquired a new position in CVS Health Corporation (NYSE:CVS) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 3,822 shares of the pharmacy operator’s stock, valued at approximately $259,000.

Other institutional investors have also added to or reduced their stakes in the company. Hopwood Financial Services Inc. bought a new stake in CVS Health in the 4th quarter worth about $29,000. McIlrath & Eck LLC grew its position in CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 174 shares in the last quarter. Financial Perspectives Inc grew its position in CVS Health by 137.5% in the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator’s stock worth $36,000 after purchasing an additional 466 shares in the last quarter. Compass Planning Associates Inc bought a new stake in CVS Health in the 4th quarter worth about $37,000. Finally, Providence First Trust Co bought a new stake in CVS Health in the 4th quarter worth about $42,000. 80.66% of the stock is owned by institutional investors.

CVS Health Stock Down 0.3%

CVS opened at $66.91 on Friday. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $72.51. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The company has a market cap of $84.64 billion, a PE ratio of 15.97, a price-to-earnings-growth ratio of 0.96 and a beta of 0.56. The company has a 50 day moving average of $64.98 and a 200 day moving average of $60.35.

CVS Health (NYSE:CVS) last posted its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business had revenue of $94.59 billion for the quarter, compared to analysts’ expectations of $93.07 billion. During the same period in the prior year, the company posted $1.31 EPS. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. On average, sell-side analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have issued reports on CVS. UBS Group upped their price objective on shares of CVS Health from $67.00 to $71.00 and gave the stock a “neutral” rating in a research report on Friday, May 2nd. Piper Sandler increased their target price on shares of CVS Health from $72.00 to $74.00 and gave the company an “overweight” rating in a research report on Friday, March 21st. Cowen reissued a “buy” rating on shares of CVS Health in a research report on Monday, May 5th. Wells Fargo & Company reissued an “overweight” rating and set a $84.00 target price (up from $76.00) on shares of CVS Health in a research report on Tuesday, May 6th. Finally, Barclays set a $79.00 target price on shares of CVS Health and gave the company an “overweight” rating in a research report on Monday, June 2nd. Two research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $74.75.

Insiders Place Their Bets

In other news, Director Guy P. Sansone bought 1,570 shares of the stock in a transaction on Thursday, June 5th. The shares were acquired at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the purchase, the director now directly owns 12,007 shares of the company’s stock, valued at $764,845.90. This trade represents a 15.04% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.22% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.